Chunlin Yang
26Patents
15h-index
68Co-inventors
80Inventor score
Filing activity: Mar 31, 2006 → Sep 22, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9301753B2 | Expandable tissue thickness compensator | Human Necessities | 1,715 | Active |
| US9232941B2 | Tissue thickness compensator comprising a reservoir | Human Necessities | 1,535 | Active |
| US9301752B2 | Tissue thickness compensator comprising a plurality of capsules | Human Necessities | 1,470 | Active |
| US9277919B2 | Tissue thickness compensator comprising fibers to produce a resilient load | Mechanical Engineering; Lighting; Heating | 1,466 | Active |
| US9320518B2 | Tissue stapler having a thickness compensator incorporating an oxygen generating agent | Human Necessities | 1,436 | Active |
| US9480476B2 | Tissue thickness compensator comprising resilient members | Mechanical Engineering; Lighting; Heating | 1,423 | Active |
| US8034363B2 | Sustained release systems of ascorbic acid phosphate | Human Necessities | 1,368 | Active |
| US9332974B2 | Layered tissue thickness compensator | Human Necessities | 1,299 | Active |
| US9414838B2 | Tissue thickness compensator comprised of a plurality of materials | Human Necessities | 1,269 | Active |
| US9572574B2 | Tissue thickness compensators comprising therapeutic agents | Human Necessities | 1,105 | Active |
| US9808247B2 | Stapling system comprising implantable layers | Human Necessities | 1,097 | Active |
| US9795383B2 | Tissue thickness compensator comprising resilient members | Mechanical Engineering; Lighting; Heating | 997 | Active |
| US10258330B2 | End effector including an implantable arrangement | Human Necessities | 854 | Active |
| US9044397B2 | Medical devices with galvanic particulates | Human Necessities | 21 | Active |
| US8936651B2 | Decellularized omentum matrix and uses thereof | Performing Operations; Transporting | 15 | Active |
| US7927414B2 | Method of manufacturing acellular matrix glue | Human Necessities | 11 | Active |
| US8076294B2 | Collagen-related peptides and uses thereof | Physics | 6 | Active |
| US9028851B2 | Hemostatic materials and devices with galvanic particulates | Human Necessities | 5 | Active |
| US8822423B2 | Affinity peptides toward infliximab | Chemistry; Metallurgy | 0 | Active |
| US8858698B2 | Acellular matrix glue | Emerging Cross-Sectional Technologies | 0 | Active |
| US8629106B2 | Affinity peptides toward BMP-2 | Chemistry; Metallurgy | 0 | Active |
| US8197838B2 | Sustained release systems of ascorbic acid phosphate | Human Necessities | 0 | Active |
| US7927676B2 | Plasma-treated vascular occlusion devices and methods | Emerging Cross-Sectional Technologies | 0 | Active |
| US9248194B2 | Affinity peptides toward infliximab | Chemistry; Metallurgy | 0 | Active |
| US9290742B2 | Tissue engineered blood vessel | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.